Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-07

Clinical Trial Update: FACBC for Recurrent Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for FACBC in recurrent prostate cancer with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FACBC

Snippet

Sponsor: David M. Schuster, MD | Conditions: Recurrent Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-01-07